PREVENT ESRD Act
Latest action (22 Jul 2026): Introduced
What this bill does
H.R. 9891, the PREVENT ESRD Act, directs the Secretary of Health and Human Services to establish a listening session on kidney disease within 180 days of enactment, bringing together clinicians, patients, health plans, and other experts to identify ways to improve early screening and treatment. The bill's main provision creates a 10-year Medicare demonstration program, to begin by January 1, 2027, that allows health plans—including commercial group and individual insurers, Medicaid programs, and Medicare Advantage plans—to voluntarily participate in efforts to prevent chronic kidney disease from progressing to end-stage renal disease (ESRD).
Participating plans would be required to cover specified kidney-related screening, drugs, nutrition support, and disease-management services with minimal cost-sharing, and to submit data on disease progression and outcomes. In return, plans meeting performance benchmarks could receive a share (25 percent) of the resulting Medicare savings, and may also receive advance "investment" payments to support program compliance. The Secretary would monitor and evaluate results, report to Congress at the 3- and 6-year marks, and fund the program through Medicare trust funds.
The bill affects Medicare, Medicaid, and private insurance plans, as well as individuals diagnosed with kidney disease. It was introduced on July 22, 2026, by Rep. Joe Wilson and referred to the House Committees on Energy and Commerce and Ways and Means; no further action has occurred.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
This bill is in the first stage of the legislative process. It was introduced into Congress on July 22, 2026. It will typically be considered by committee next before it is possibly sent on to the House or Senate as a whole.
Common questions
- What does H.R. 9891 do?
- H.R. 9891, the PREVENT ESRD Act, directs the Secretary of Health and Human Services to establish a listening session on kidney disease within 180 days of enactment, bringing together clinicians, patients, health plans, and other experts to identify ways to improve early screening and treatment. The bill's main provision creates a 10-year Medicare demonstration program, to begin by January 1, 2027, that allows health plans—including commercial group and individual insurers, Medicaid programs, and Medicare Advantage plans—to voluntarily participate in efforts to prevent chronic kidney disease from progressing to end-stage renal disease (ESRD). Participating plans would be required to cover specified kidney-related screening, drugs, nutrition support, and disease-management services with minimal cost-sharing, and to submit data on disease progression and outcomes. In return, plans meeting performance benchmarks could receive a share (25 percent) of the resulting Medicare savings, and may also receive advance "investment" payments to support program compliance. The Secretary would monitor and evaluate results, report to Congress at the 3- and 6-year marks, and fund the program through Medicare trust funds. The bill affects Medicare, Medicaid, and private insurance plans, as well as individuals diagnosed with kidney disease. It was introduced on July 22, 2026, by Rep. Joe Wilson and referred to the House Committees on Energy and Commerce and Ways and Means; no further action has occurred.
- Has H.R. 9891 become law?
- Not yet. As of 22 Jul 2026, H.R. 9891 is introduced.
- Who sponsored H.R. 9891?
- H.R. 9891 was sponsored by Rep. Joe Wilson [R-SC2] (Republican-SC), with 0 cosponsors.
- What's the latest action on H.R. 9891?
- Introduced (22 Jul 2026).
Related bills in Health
Expressing support for the designation of September 22, 2026, as “National Hispanic Nurses Day” and recognizing the National Association of Hispanic Nurses as the leading organization representing and advocating for Hispanic nurses.
Recognizing the importance of protecting continuous Medicaid coverage for individuals undergoing active cancer treatment.
Wildland Firefighter Health and Safety Act
Expressing support for the designation of the third week of September as “Fungal Disease Awareness Week” and encouraging efforts to improve awareness, diagnosis, treatment, surveillance, and prevention of fungal diseases in the United States.
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.